Free Trial

HealthStream (HSTM) Competitors

HealthStream logo
$33.85 +0.39 (+1.17%)
As of 01:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.

HSTM vs. SDGR, CERT, GDRX, TDOC, and PHR

Should you buy HealthStream stock or one of its competitors? HealthStream's main competitors and comparable companies include Schrodinger (SDGR), Certara (CERT), GoodRx (GDRX), Teladoc Health (TDOC), and Phreesia (PHR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does HealthStream compare to Schrodinger?

Schrodinger (NASDAQ:SDGR) and HealthStream (NASDAQ:HSTM) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.

HealthStream has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Schrodinger$255.87M7.48-$103.26M-$0.74N/A
HealthStream$321.12M3.04$18.34M$0.7246.47

In the previous week, Schrodinger had 4 more articles in the media than HealthStream. MarketBeat recorded 9 mentions for Schrodinger and 5 mentions for HealthStream. Schrodinger's average media sentiment score of 0.66 beat HealthStream's score of 0.44 indicating that Schrodinger is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Schrodinger
1 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
HealthStream
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

79.1% of Schrodinger shares are owned by institutional investors. Comparatively, 69.6% of HealthStream shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by insiders. Comparatively, 20.4% of HealthStream shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Schrodinger has a beta of 1.62, meaning that its share price is 62% more volatile than the broader market. Comparatively, HealthStream has a beta of 0.42, meaning that its share price is 58% less volatile than the broader market.

Schrodinger presently has a consensus price target of $22.33, suggesting a potential downside of 13.80%. HealthStream has a consensus price target of $27.00, suggesting a potential downside of 19.31%. Given Schrodinger's stronger consensus rating and higher possible upside, equities analysts plainly believe Schrodinger is more favorable than HealthStream.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Schrodinger
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.63
HealthStream
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

HealthStream has a net margin of 6.60% compared to Schrodinger's net margin of -20.98%. HealthStream's return on equity of 6.81% beat Schrodinger's return on equity.

Company Net Margins Return on Equity Return on Assets
Schrodinger-20.98% -16.37% -8.19%
HealthStream 6.60%6.81%4.64%

Summary

Schrodinger beats HealthStream on 9 of the 17 factors compared between the two stocks.

How does HealthStream compare to Certara?

HealthStream (NASDAQ:HSTM) and Certara (NASDAQ:CERT) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends and profitability.

HealthStream has a net margin of 6.60% compared to Certara's net margin of -16.75%. HealthStream's return on equity of 6.81% beat Certara's return on equity.

Company Net Margins Return on Equity Return on Assets
HealthStream6.60% 6.81% 4.64%
Certara -16.75%3.86%2.65%

HealthStream presently has a consensus target price of $27.00, suggesting a potential downside of 19.31%. Certara has a consensus target price of $8.60, suggesting a potential downside of 6.93%. Given Certara's stronger consensus rating and higher probable upside, analysts clearly believe Certara is more favorable than HealthStream.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HealthStream
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Certara
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.42

69.6% of HealthStream shares are held by institutional investors. Comparatively, 74.0% of Certara shares are held by institutional investors. 20.4% of HealthStream shares are held by company insiders. Comparatively, 1.1% of Certara shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Certara had 6 more articles in the media than HealthStream. MarketBeat recorded 11 mentions for Certara and 5 mentions for HealthStream. Certara's average media sentiment score of 0.89 beat HealthStream's score of 0.44 indicating that Certara is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HealthStream
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Certara
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

HealthStream has higher earnings, but lower revenue than Certara. Certara is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HealthStream$321.12M3.04$18.34M$0.7246.47
Certara$418.84M3.37-$1.60M-$0.45N/A

HealthStream has a beta of 0.42, meaning that its share price is 58% less volatile than the broader market. Comparatively, Certara has a beta of 1.42, meaning that its share price is 42% more volatile than the broader market.

Summary

Certara beats HealthStream on 10 of the 17 factors compared between the two stocks.

How does HealthStream compare to GoodRx?

GoodRx (NASDAQ:GDRX) and HealthStream (NASDAQ:HSTM) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

GoodRx presently has a consensus target price of $4.23, suggesting a potential upside of 21.47%. HealthStream has a consensus target price of $27.00, suggesting a potential downside of 19.31%. Given GoodRx's higher probable upside, equities research analysts clearly believe GoodRx is more favorable than HealthStream.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GoodRx
3 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.08
HealthStream
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

HealthStream has a net margin of 6.60% compared to GoodRx's net margin of 2.07%. GoodRx's return on equity of 7.22% beat HealthStream's return on equity.

Company Net Margins Return on Equity Return on Assets
GoodRx2.07% 7.22% 2.53%
HealthStream 6.60%6.81%4.64%

GoodRx has a beta of 1.69, suggesting that its share price is 69% more volatile than the broader market. Comparatively, HealthStream has a beta of 0.42, suggesting that its share price is 58% less volatile than the broader market.

GoodRx has higher revenue and earnings than HealthStream. HealthStream is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GoodRx$796.85M1.50$30.44M$0.0487.00
HealthStream$321.12M3.04$18.34M$0.7246.47

In the previous week, HealthStream had 4 more articles in the media than GoodRx. MarketBeat recorded 5 mentions for HealthStream and 1 mentions for GoodRx. GoodRx's average media sentiment score of 0.60 beat HealthStream's score of 0.44 indicating that GoodRx is being referred to more favorably in the media.

Company Overall Sentiment
GoodRx Positive
HealthStream Neutral

63.8% of GoodRx shares are owned by institutional investors. Comparatively, 69.6% of HealthStream shares are owned by institutional investors. 5.9% of GoodRx shares are owned by insiders. Comparatively, 20.4% of HealthStream shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

GoodRx and HealthStream tied by winning 8 of the 16 factors compared between the two stocks.

How does HealthStream compare to Teladoc Health?

Teladoc Health (NYSE:TDOC) and HealthStream (NASDAQ:HSTM) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

76.8% of Teladoc Health shares are held by institutional investors. Comparatively, 69.6% of HealthStream shares are held by institutional investors. 0.7% of Teladoc Health shares are held by insiders. Comparatively, 20.4% of HealthStream shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

HealthStream has a net margin of 6.60% compared to Teladoc Health's net margin of -7.13%. HealthStream's return on equity of 6.81% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Teladoc Health-7.13% -12.15% -5.83%
HealthStream 6.60%6.81%4.64%

HealthStream has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teladoc Health$2.53B0.43-$200.32M-$0.99N/A
HealthStream$321.12M3.04$18.34M$0.7246.47

Teladoc Health has a beta of 2.14, suggesting that its stock price is 114% more volatile than the broader market. Comparatively, HealthStream has a beta of 0.42, suggesting that its stock price is 58% less volatile than the broader market.

In the previous week, Teladoc Health had 5 more articles in the media than HealthStream. MarketBeat recorded 10 mentions for Teladoc Health and 5 mentions for HealthStream. Teladoc Health's average media sentiment score of 0.62 beat HealthStream's score of 0.44 indicating that Teladoc Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teladoc Health
4 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
HealthStream
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Teladoc Health presently has a consensus price target of $7.54, suggesting a potential upside of 27.19%. HealthStream has a consensus price target of $27.00, suggesting a potential downside of 19.31%. Given Teladoc Health's higher possible upside, equities research analysts clearly believe Teladoc Health is more favorable than HealthStream.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teladoc Health
1 Sell rating(s)
10 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.25
HealthStream
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

HealthStream beats Teladoc Health on 9 of the 16 factors compared between the two stocks.

How does HealthStream compare to Phreesia?

Phreesia (NYSE:PHR) and HealthStream (NASDAQ:HSTM) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends.

HealthStream has lower revenue, but higher earnings than Phreesia. HealthStream is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Phreesia$480.59M1.40$2.31M$0.1763.85
HealthStream$321.12M3.04$18.34M$0.7246.47

Phreesia has a beta of 0.84, meaning that its stock price is 16% less volatile than the broader market. Comparatively, HealthStream has a beta of 0.42, meaning that its stock price is 58% less volatile than the broader market.

HealthStream has a net margin of 6.60% compared to Phreesia's net margin of 2.06%. HealthStream's return on equity of 6.81% beat Phreesia's return on equity.

Company Net Margins Return on Equity Return on Assets
Phreesia2.06% 5.22% 3.02%
HealthStream 6.60%6.81%4.64%

Phreesia presently has a consensus price target of $14.07, indicating a potential upside of 29.60%. HealthStream has a consensus price target of $27.00, indicating a potential downside of 19.31%. Given Phreesia's stronger consensus rating and higher probable upside, equities research analysts plainly believe Phreesia is more favorable than HealthStream.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Phreesia
1 Sell rating(s)
10 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.37
HealthStream
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

In the previous week, Phreesia and Phreesia both had 5 articles in the media. HealthStream's average media sentiment score of 0.44 beat Phreesia's score of 0.16 indicating that HealthStream is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Phreesia
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
HealthStream
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

92.1% of Phreesia shares are owned by institutional investors. Comparatively, 69.6% of HealthStream shares are owned by institutional investors. 5.2% of Phreesia shares are owned by company insiders. Comparatively, 20.4% of HealthStream shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

HealthStream beats Phreesia on 8 of the 15 factors compared between the two stocks.

Get HealthStream News Delivered to You Automatically

Sign up to receive the latest news and ratings for HSTM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSTM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HSTM vs. The Competition

MetricHealthStreamHealthcare Technology IndustryHealthcare SectorNASDAQ Exchange
Market Cap$988.93M$1.93B$7.18B$13.17B
Dividend Yield0.43%3.95%2.52%20.73%
P/E Ratio47.0121.95275.5825.75
Price / Sales3.0893.90619.65102.39
Price / Cash12.7232.1227.3036.12
Price / Book2.846.1310.716.04
Net Income$18.34M-$19.09M$3.50B$380.34M
7 Day Performance8.12%-1.38%-2.47%-2.69%
1 Month Performance16.29%-0.69%-5.97%-4.89%
1 Year Performance33.33%-19.99%4.73%-2.27%

HealthStream Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HSTM
HealthStream
2.0195 of 5 stars
$33.85
+1.2%
$27.00
-20.2%
+30.7%$988.93M$321.12M47.011,160
SDGR
Schrodinger
2.3116 of 5 stars
$28.94
-11.2%
$20.80
-28.1%
+35.8%$2.13B$259.04MN/A850
CERT
Certara
1.9859 of 5 stars
$9.36
-7.1%
$8.45
-9.7%
-22.1%$1.43B$421.75MN/A1,576
GDRX
GoodRx
4.3323 of 5 stars
$3.31
-1.6%
$4.23
+27.9%
-18.5%$1.13B$785.23M82.65697
TDOC
Teladoc Health
2.831 of 5 stars
$5.83
+0.6%
$7.54
+29.4%
-26.1%$1.06B$2.49BN/A5,600

Related Companies and Tools


This page (NASDAQ:HSTM) was last updated on 10/13/2026 by MarketBeat.com Staff.
From Our Partners